Alexandria Real Estate Equities Stock News

Recent economic data has weakened market optimism. Gold has hit record highs, Treasury yields have fallen, and the dollar index continues to deteriorate as investors seek safety. Despite negative economic signals, growth-driven stocks have reached new highs, defying broader market caution.

Highlighting 10 S&P-rated companies with 4-7% yields, focusing on dividend growth, credit quality, and undervaluation. Pfizer, Alexandria RE, NNN REIT, AES Corp, and Bristol Myers are identified as undervalued winners and recommended as buys for income-focused investors.

When it comes to dividend yields, bigger may not always be better.

Alexandria is now trading at just one-third of its peak valuation. We think that this is due to a temporary issue. We estimate fair value at a 2x higher share price.

Sixteen of the thirty-eight highest-yield, 'safer' S&P 500 dividend stocks are highlighted as ready to buy, with adequate free cash flow supporting payouts. Analyst forecasts suggest top ten S&P 500 dividend 'dogs' could deliver 20.45% to 38.5% net gains by September 2026, with an average gain of 27.35%. Stocks like Amcor, Healthpeak, Conagra, Pfizer, and Verizon offer the best combination of h...

REIT investors are attracted to high-yielding opportunities. But many of the highest-yielding REITs are risky. I highlight two popular high-yielding REITs to avoid.

There's more than one way to invest in the healthcare sector. In fact, if you are looking for dividend income, you'll probably need to consider your alternatives, given the sector's measly 1.7% average yield.

Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.